ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.903,39
1,31%
S&P 500
5.996,66
1,00%
Dow Jones
43.487,83
0,78%
Euro vs US Dollar
1,027
0,00%
Bitcoin
104.862,14
0,42%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC

  6. Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF) Börsenkurse

Parnell Pharmaceuticals Holdings Ltd (CE)

Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF)

USOTC
0,12
0,00
(0,00%)
Geschlossen 19 Januar 10:00PM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
0,12
Gebot
0,00
Fragen
0,00
Volumen
4
0,00 Tagesbereich 0,00
0,000001 52-Wochen-Bereich 0,35
Marktkapitalisierung
14,445M
Handelsende
0,12
Handelsbeginn
-
Letzte Trade
4
@
0.0021
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
28.467
Ausgegebene Aktien
120.377.529
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,52
Gewinn pro Aktie (EPS)
-0,05
Erlöse
35,43M
Nettogewinn
-5,74M

Über Parnell Pharmaceuticals Holdings Ltd (CE)

Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed... Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed via its dedicated sales force and digital technology mySYNCH in the USA and Australia-New Zealand, and via distributors in other markets. Parnell has a rapidly growing contract manufacturing business supplying industry majors with specialized sterile injectable products. In companion animal, Parnell manufactures and markets its proprietary canine osteoarthritis brands Zydax and Glyde. For more information on the company and its products, please visit www.parnell.com. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.parnell.com
Hauptsitz
Sydney, New South Wales, Aus
Gegründet
-
Parnell Pharmaceuticals Holdings Ltd (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker PARNF. The last closing price for Parnell Pharmaceuticals (CE) was US$0,12. Over the last year, Parnell Pharmaceuticals (CE) shares have traded in a share price range of US$ 0,000001 to US$ 0,35.

Parnell Pharmaceuticals (CE) currently has 120.377.529 shares in issue. The market capitalisation of Parnell Pharmaceuticals (CE) is US$14,45 million. Parnell Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of -2.52.

PARNF Neueste Nachrichten

Weitere Nachrichten

Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ

OVERLAND PARK, Kan., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

19 Dezember 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the...

OVERLAND PARK, Kan., Dec. 09, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

09 Dezember 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility

OVERLAND PARK, Kan., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

23 November 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016

OVERLAND PARK, Kansas, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

02 November 2016
GlobeNewswire Inc.

Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016

OVERLAND PARK, Kan., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

27 Oktober 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016

OVERLAND PARK, Kan., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

04 August 2016
GlobeNewswire Inc.

Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016

OVERLAND PARK, Kan., July 26, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

26 Juli 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial

OVERLAND PARK, Kan., May 31, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

31 Mai 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Pricing of an Underwritten Public Offering of Common Stock

OVERLAND PARK, Kan., May 12, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

12 Mai 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Update

Parnell continues to grow rapidly with revenue increasing 43% for the three months ended March 31, 2016OVERLAND PARK, Kan., April 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings...

22 April 2016
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.120.120.125000.12CS
40.03846.34146341460.0820.180.082195800.1423284CS
120.071400.050.350.05284670.08767723CS
260.11991199000.00010.351.0E-6206910.08616385CS
520.119999119999001.0E-60.351.0E-6148680.08393423CS
1560.11991199000.00010.351.0E-6133180.02880215CS
2600.029933.18534961150.09010.891.0E-6124140.21483978CS

PARNF - Frequently Asked Questions (FAQ)

What is the current Parnell Pharmaceuticals (CE) share price?
The current share price of Parnell Pharmaceuticals (CE) is US$ 0,12
How many Parnell Pharmaceuticals (CE) shares are in issue?
Parnell Pharmaceuticals (CE) has 120.377.529 shares in issue
What is the market cap of Parnell Pharmaceuticals (CE)?
The market capitalisation of Parnell Pharmaceuticals (CE) is USD 14,45M
What is the 1 year trading range for Parnell Pharmaceuticals (CE) share price?
Parnell Pharmaceuticals (CE) has traded in the range of US$ 0,000001 to US$ 0,35 during the past year
What is the PE ratio of Parnell Pharmaceuticals (CE)?
The price to earnings ratio of Parnell Pharmaceuticals (CE) is -2,52
What is the cash to sales ratio of Parnell Pharmaceuticals (CE)?
The cash to sales ratio of Parnell Pharmaceuticals (CE) is 0,41
What is the reporting currency for Parnell Pharmaceuticals (CE)?
Parnell Pharmaceuticals (CE) reports financial results in AUD
What is the latest annual turnover for Parnell Pharmaceuticals (CE)?
The latest annual turnover of Parnell Pharmaceuticals (CE) is AUD 35,43M
What is the latest annual profit for Parnell Pharmaceuticals (CE)?
The latest annual profit of Parnell Pharmaceuticals (CE) is AUD -5,74M
What is the registered address of Parnell Pharmaceuticals (CE)?
The registered address for Parnell Pharmaceuticals (CE) is UNIT 4 CENTURY ESTATE, 476 GARDENERS ROAD, ALEXANDRIA, SYDNEY, NEW SOUTH WALES, 2015
What is the Parnell Pharmaceuticals (CE) website address?
The website address for Parnell Pharmaceuticals (CE) is www.parnell.com
Which industry sector does Parnell Pharmaceuticals (CE) operate in?
Parnell Pharmaceuticals (CE) operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TMGIMarquie Group Inc (PK)
US$ 0,0002
(19.900,00%)
4,03M
SEANSAEAN Group Inc (PK)
US$ 1,87
(18.600,00%)
100
BRGOBergio International Inc (PK)
US$ 0,0001
(9.900,00%)
540k
GMPRGourmet Provisions International Corporation (PK)
US$ 0,0001
(9.900,00%)
35,31M
PLPLPlandai Biotechnology Inc (PK)
US$ 0,0001
(9.900,00%)
18,06M
STNXStartronix International Inc (CE)
US$ 0,000001
(-99,99%)
450
AWINAERWINS Technologies Inc (CE)
US$ 0,000001
(-99,97%)
2,03k
ISOLImage Software Inc (CE)
US$ 0,000001
(-99,91%)
59,2k
NBIONascent Biotech Inc (CE)
US$ 0,0002
(-99,55%)
8,7k
FHBCFernhill Beverage Inc (CE)
US$ 0,000001
(-99,24%)
10k
GTCHGBT Technologies Inc (PK)
US$ 0,0001
(0,00%)
349,77M
VTXBVortex Brands Company (PK)
US$ 0,0002
(0,00%)
297,52M
EMEDElectroMedical Technologies Inc (PK)
US$ 0,0002
(0,00%)
233,53M
PHILPHI Group Inc (PK)
US$ 0,0002
(-33,33%)
184,12M
HMBLHUMBL Inc (PK)
US$ 0,0009
(-5,26%)
179,2M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

USOTC
PARNF
Parnell Pharmaceuticals (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten